Overview
Melissa Koziatek is a Nurse Practitioner in Commack, New York. Her top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Classical Hodgkin Lymphoma.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- OTHER MANAGED MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
650 Commack Rd, Commack, NY 11725
Additional Areas of Focus
Koziatek has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Weill Medical College Of Cornell
Karen Pekle is a Nurse Practitioner in New York, New York. Ms. Pekle is highly rated in 2 conditions, according to our data. Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM) and Smoldering Multiple Myeloma.
New York Cancer & Blood Specialists
Denise Albano is a Nurse Practitioner in East Setauket, New York. Ms. Albano is highly rated in 2 conditions, according to our data. Her top areas of expertise are Lung Nodules and ALK-Positive Non-Small Cell Lung Cancer.
Yale New Haven Hospital
Emily Duffield is a Nurse Practitioner in New Haven, Connecticut. Ms. Duffield is highly rated in 1 condition, according to our data. Her top area of expertise is ALK-Positive Non-Small Cell Lung Cancer.
Frequently Asked Questions about Melissa Koziatek, NP
How do I make an appointment with Melissa Koziatek, NP?
You can book an appointment with Melissa Koziatek, NP by calling their office at 212-639-7900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Melissa Koziatek, NP a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Melissa Koziatek, NP is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Melissa Koziatek, NP specialize in?
While Melissa Koziatek, NP is a Nurse Practitioner, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Nurse Practitioner.
Does Melissa Koziatek, NP accept my insurance?
Melissa Koziatek, NP accepts most major insurance plans, including Anthem BCBS and Cigna. We recommend calling the office directly at 212-639-7900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerMs. Koziatek isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Classical Hodgkin LymphomaMs. Koziatek isExperienced. Learn about Classical Hodgkin Lymphoma.
- EmphysemaMs. Koziatek isExperienced. Learn about Emphysema.
- Gallbladder AdenocarcinomaMs. Koziatek isExperienced. Learn about Gallbladder Adenocarcinoma.
- Lung NodulesMs. Koziatek isExperienced. Learn about Lung Nodules.
- Muscle Invasive Bladder CancerMs. Koziatek isExperienced. Learn about Muscle Invasive Bladder Cancer.